BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 24467716)

  • 21. Craniopharyngioma.
    Garnett MR; Puget S; Grill J; Sainte-Rose C
    Orphanet J Rare Dis; 2007 Apr; 2():18. PubMed ID: 17425791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric sellar tumors: diagnostic procedures and management.
    Jagannathan J; Dumont AS; Jane JA; Laws ER
    Neurosurg Focus; 2005 Jun; 18(6A):E6. PubMed ID: 16048292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.
    Müller HL; Gebhardt U; Etavard-Gorris N; Kolb R; Warmuth-Metz M; Sörensen N
    Onkologie; 2005 Mar; 28(3):150-6. PubMed ID: 15772466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up.
    Müller HL; Gebhardt U; Schröder S; Pohl F; Kortmann RD; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Calaminus G; Kolb R; Wiegand C; Sörensen N;
    Horm Res Paediatr; 2010; 73(3):175-80. PubMed ID: 20197669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients.
    Müller HL
    Minerva Endocrinol; 2017 Dec; 42(4):356-375. PubMed ID: 28181780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Craniopharyngiomas.
    Karavitaki N; Cudlip S; Adams CB; Wass JA
    Endocr Rev; 2006 Jun; 27(4):371-97. PubMed ID: 16543382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up.
    Müller HL; Gebhardt U; Teske C; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Pohl F; Sörensen N; Calaminus G;
    Eur J Endocrinol; 2011 Jul; 165(1):17-24. PubMed ID: 21490122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Childhood craniopharyngioma - current status and recent perspectives in diagnostics and treatment.
    Müller HL
    J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):1-2. PubMed ID: 25503668
    [No Abstract]   [Full Text] [Related]  

  • 29. Relapse pattern after complete resection and early progression after incomplete resection of childhood craniopharyngioma.
    Müller HL; Gebhardt U; Pohl F; Flentje M; Emser A; Warmuth-Metz M; Kolb R; Calaminus G; Sörensen N
    Klin Padiatr; 2006; 218(6):315-20. PubMed ID: 17080333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary tumors in childhood.
    Harrington MH; Casella SJ
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):63-7. PubMed ID: 22157404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary Biological Insights and Clinical Management of Craniopharyngioma.
    Apps JR; Muller HL; Hankinson TC; Yock TI; Martinez-Barbera JP
    Endocr Rev; 2023 May; 44(3):518-538. PubMed ID: 36574377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis.
    Hoffmann A; Boekhoff S; Gebhardt U; Sterkenburg AS; Daubenbüchel AM; Eveslage M; Müller HL
    Eur J Endocrinol; 2015 Dec; 173(6):853-62. PubMed ID: 26392473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CranioNet -- an interdisciplinary strategy for craniopharyngioma].
    Reschke K; Busse S; Mohnike K; Buchfelder M; Ranke M; Fahlbusch R; Lehnert H
    Dtsch Med Wochenschr; 2006 Apr; 131(15):821-4. PubMed ID: 16607603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxytocin in survivors of childhood-onset craniopharyngioma.
    Daubenbüchel AM; Hoffmann A; Eveslage M; Özyurt J; Lohle K; Reichel J; Thiel CM; Martens H; Geenen V; Müller HL
    Endocrine; 2016 Nov; 54(2):524-531. PubMed ID: 27585663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Craniopharyngiomas].
    Van Effenterre R; Boch AL
    Ann Endocrinol (Paris); 2007 Dec; 68(6):412-21. PubMed ID: 17825241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Craniopharyngiomas: progress in pathogenesis and therapeutics].
    Hage M; Lombès M; Chanson P
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S46-54. PubMed ID: 25617922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of pediatric sellar tumors.
    Jane JA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():720-6. PubMed ID: 18317443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric craniopharyngioma: a 20-year study on epidemiological features, clinical presentation, and survival outcomes in a tertiary care center from LMIC.
    Memon F; Humayun KN; Riaz Q; Arif M; Huda NU; Laghari AA; Hilal K; Mushtaq N
    Childs Nerv Syst; 2024 Feb; 40(2):427-434. PubMed ID: 37837454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical strategies and modern therapeutic options in the treatment of craniopharyngiomas.
    Mortini P; Gagliardi F; Boari N; Losa M
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):514-29. PubMed ID: 23932582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical approach to parasellar lesions in the transition age.
    Sbardella E; Puliani G; Feola T; Pofi R; Pirchio R; Sesti F; Verdecchia F; Gianfrilli D; Moffat D; Isidori AM; Grossman AB;
    J Neuroendocrinol; 2021 Jun; 33(6):e12995. PubMed ID: 34138496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.